β8 is also expressed on Tregs, and in murine models of melanoma and breast cancer, αvβ8 expressing Tregs activated TGFβ that was required to promote anti-tumour immunity, while ex vivo treatment of patient samples with anti-β8 antibodies improved cytotoxic T cell activity in tumour explants. This evidence concerns the gene TGFB1 and melanoma.